|
000
| 02339cam 2200325za 4500 |
|---|
| 001 | 9.840166 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107151757 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180119s2017 onc ob f000 0 eng d |
|---|
| 020 | |a978-0-660-09142-6 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-1/2017-3-1E-PDF |
|---|
| 245 | 00|aCanadian guidelines on sexually transmitted infections |h[electronic resource] : |btreatment of N. gonorrhoeae in response to the discontinuation of spectinomycin : alternative treatment guidance statement. |
|---|
| 246 | 30|aTreatment of N. gonorrhoeae in response to the discontinuation of spectinomycin : |balternative treatment guidance statement |
|---|
| 250 | |aRevised July 2017. |
|---|
| 260 | |a[Ottawa] : |bPublic Health Agency of Canada, |c2017. |
|---|
| 300 | |a4 p. |
|---|
| 500 | |aIssued also in French under title: Lignes directrices canadiennes sur les infections transmissibles sexuellement. Traitement des infections gonococciques par suite du retrait du marché de la spectinomycine : déclaration d’orientation pour les traitements de remplacement. |
|---|
| 500 | |aCaption title. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The Public Health Agency of Canada (PHAC) has been informed that manufacturing of spectinomycin has been discontinued. Spectinomycin is recommended in the Canadian Guidelines on Sexually Transmitted Infections (CGSTI) as part of an alternate combination therapy for anogenital Neisseria gonorrhoeae infection, in individuals with contraindications to first-line treatment (i.e., cephalosporins given in combination with azithromycin or doxycycline). This guidance statement for alternative treatments for gonococcal infections was developed in consultation with the CGSTI Expert Working Group based on Canadian epidemiology and a rapid evidence review”--Issue, p. 1. |
|---|
| 692 | 07|2gccst|aSexually transmitted diseases |
|---|
| 692 | 07|2gccst|aMedicine |
|---|
| 692 | 07|2gccst|aGuidelines |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |
|---|
| 775 | 08|tLignes directrices canadiennes sur les infections transmissibles sexuellement |w(CaOODSP)9.840167 |
|---|
| 795 | |tCanadian guidelines on sexually transmitted infections |w(CaOODSP)9.836313 |
|---|
| 856 | 40|qPDF|s364 KB|uhttps://publications.gc.ca/collections/collection_2018/aspc-phac/HP40-1-2017-3-1-eng.pdf |
|---|